Study Investigates Hypomethylation Immunotherapy Combination in Bladder Cancer
PHILADELPHIA (May 12, 2023)—Immunotherapy has become a powerful tool to fight many cancers, but it still only works in some patients and researchers are looking for new options to help patients who become resistant.